Antioxidant Effects of <i>Eryngium carlinae</i> in Diabetic Rats
Keywords:Antioxidants, Cardiovascular disease, Diabetes, Hypoglycemia, Oxidative stress
Metabolic diseases have increased considerably such as diabetes mellitus (DM). Since diabetes is a systemic disease, it implies high cardiovascular risks. It has been widely established that cardiac injury is related to mitochondrial dysfunction through increment of reactive oxygen species (ROS). Synthetic antioxidants can have important side effects; therefore natural sources may represent a better option. Traditional Mexican medicine has been using Eryngium carlinae (EC) for medical treatment. Also our group showed that hexanic extract possesses in vitro antioxidant capacity. Experimental diabetes in Wistar rats was generated by streptozotocin (STZ) and hexanic extract of EC was supplied for 7 weeks (30 mg/kg). Cholesterol, triacylglycerides, glucose, and thiobarbituric acid reactive substances (TBARS) levels were determined in serum. Mitochondria from left ventricle were used in the quantification of TBARS, reduced glutathione, nitric oxide (NO) levels and activity of superoxide dismutase (SOD) enzyme was performed.Â Biochemical parameters of glucose and triacylglycerides, as well as TBARS levels in serum show a significant reduction in diabetic group supplied with EC hexanic extract. Thus, we can conclude that the EC hexanic extract possesses antioxidant activity in vitro, and in vivo, by reducing glucose and triacylglycerides levels during hyperglycemia, which may eventually reduce the risk of developing diabetic cardiomyopathy.
G. EngstrÃ¶m, J.G. Smith, M. Persson, P.M. Nilsson, O. Melander, B. Hedblad, â€œRed cell distribution width, haemoglobin A1c and incidence of diabetes mellitusâ€ J. Intern. Med. vol. 276, no. 2, 174-83, 2014.
S. Vallejo, E. Palacios, T. Romacho, L. Villalobos, C. PeirÃ³, C.F. SÃ¡nchez-Ferrer, â€œThe interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic ratsâ€, Cardiovasc. Diabetol. vol. 13, pp. 158, 2014.
Y. Wang, P.T. Katzmarzyk, R. Horswell, W. Zhao, J. Johnson, G. Hu, â€œKidney function and the risk of cardiovascular disease in patients with type 2 diabetesâ€ Kidney Int. vol. 85, no. 5, pp. 1192-1199, 2014.
J.C. Ferreira Braga, F. Guimaraes Filho, F. Villaca, C.A. Padovani, B.B. Matsubara, â€œDiastolic Dysfunction in Diabetic Normotensive Patients, Regardless of the Presence of Microangiopathyâ€, Arq. Bras. Cardiol. vol. 84, no. 6, pp. 1-5, 2005.
K. Levitt, L. Vivas, B. Courtney, K.A. Connelly, â€œVascular imaging in diabetesâ€ Curr. Atheroscler. Rep. vol. 16, no. 4, pp. 399, 2014.
J.M. Forbes, M.E. Cooper, â€œMechanisms of diabetic complicationsâ€ Physiol. Rev. vol. 93, pp. 137-188. 2013.
Q. Liang, S. Kobayashi, â€œMitochondrial quality control in the diabetic heartâ€, J. Mol. Cell. Cardiol. vol. 95, pp. 57-69, 2015.
N.M. Al-Rasheed, N.M. Al-Rasheed, I.H. Hasan, M.A. Al-Amin, H.N. Al-Ajmi, A.M. Mahmoud, â€œSitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic ratsâ€, Drug Des. Devel. Ther. vol. 10, pp. 2095-2107, 2016.
X. Gao, Y. Xu, B. Xu, Y. Liu, J. Cai, H.M. Liu, S. Lei, Y.Q. Zhong, M.G. Irwin, Z. Xia, â€œAllopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetesâ€ Diabetes Metab. Res. Rev. vol. 28, pp. 409-417, 2012.
W.S. Choo, W.K. Yong, â€œAntioxidant properties of two species of Hylocereus fruitsâ€ Adv. Appl. Sci. Res. vol. 2, pp. 418-425, 2011.
R. Noriega-Cisneros, O. Ortiz-Avila, E. Esquivel-GutiÃ©rrez, M. Clemente-Guerrero, S. Manzo-Avalos, R. Salgado- Garciglia, C. CortÃ©s-Rojo, I. Boldogh, A. Saavedra-Molina, â€œHypolipidemic activity of Eryngium carlinae on streptozotocin-induced diabetic ratsâ€ Biochem. Res. Int. vol. 2012, pp. 1-5, 2012.
L.C. Cefali, E.C. Cazedey, T.M. Souza-Moreira, M.A. Correo, V.L. Isaac, â€œAntioxidant activity and validation of quantification method for lycopene extracted from tomatoâ€ J. AOAC. Int. vol. 98, no. 5, pp. 1340-1345, 2015.
M.S. Blois, â€œAntioxidant determinations by the use of a stable free radicalâ€ Nature, vol. 181, pp. 1199-1200, 1958.
H. Ohkawa, N. Ohishi, K. Yagi, â€œAssay for lipid peroxides in animal tissues by thiobarbituric acid reactionâ€ Anal. Biochem. vol. 95, no. 2, pp. 351-358. 1979.
R.J. Ruch, S.J. Cheng, J.E. Klaunig, â€œPrevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green teaâ€ Carcinogenesis, vol. 10, no. 6, pp. 1003-1008, 1989.
R. Moreno-SÃ¡nchez, R. Hansford, â€œDependence of cardiac mitochondrial pyruvate dehydrogenase activity on intramitochondrial free Ca2+ concentrationâ€ Biochem. J. vol. 256, pp. 403-412. 1988.
J. Buege, S. Aust, â€œMicrosomal lipid peroxidationâ€, Methods Enzimol., vol. 52, pp. 302-310, 1978.
D. Jollow, J.R. Mitchell, N. Zampaglione, J. Gillete, â€œBromobenzene-induced liver necrosis, protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metaboliteâ€, Pharmacology, vol. 11, pp. 151-169, 1974.
L. Green, D.G. Wagner, P. Skipper, J. Wishnok, S. Tannenbaum, â€œAnalysis of nitrate, and [15 N] nitrate in biological fluidsâ€ Anal. Biochem. vol. 126, pp. 131-138, 1982.
Y. Kayama, U. Raaz, A. Jagger, M. Adam, I.N. Schellinger, M. Sakamoto, H. Suzuki, K. Toyama, J.M. Spin, P.S. Tsao, â€œDiabetic cardiovascular disease induced by oxidative stressâ€ Int. J. Mol. Sci. vol. 16. No. 10, pp. 25234- 25263, 2015.
J. DÃez, B. LÃ³pez, A. GonzÃ¡lez, N. Ardanaz, M.A. FortuÃ±o, â€œGenetics and molecular biology in cardiology (IV). Myocardial response to biomechanical stressâ€ Rev. Esp. Cardiol. vol. 54, pp. 507-515, 2001.
R.J. Patil, R.Y. Patil, B. Ahirwar, D. Ahirwar, â€œEvaluation of antidiabetic and related actions of some Indian medicinal plants in diabetic ratsâ€ Asian Pac. J. Trop. Med. vol. 4, no. 1, pp. 20-23, 2011.
D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, T.J. Orchard, P. Raskin, B. Zinman, â€œIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesâ€ N. Engl. J. Med. vol. 35, no. 25, pp. 2643-2653, 2005.
A.M. Cordero-Reyes, A.A. Gupte, K.A. Youker, M. Loebe, W.A. Hsueh, G. Torre- Amione, H. Taegtmeyer, D.J. Hamilton, â€œFreshly isolated mitochondria from failing human hearts exhibit preserved respiratory functionâ€ J. Mol. Cell. Cardiol. vol. 68, pp. 98-105, 2014.
S. Samarghandian, A. Borji, M.B. Delkhosh, F. Samini, â€œSafranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic ratsâ€ J. Pharm. Pharm. Sci. vol. 16, no. 2, pp. 352-362, 2013.
J. Thierer, â€œInsuficiencia cardiaca y diabetesâ€ Rev. Argent. Cardiol. vol. 74, pp. 60-67, 2006.
I.H. Schulman, M.S. Zhou, L. Raij, â€œInteraction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertensionâ€ J. Hypertens. Suppl. vol. 24, no. 1, pp. S45-50, 2006.
C.A. Pieme, J.A. Tatangmo, G. Simo, P.C. Biapa Nya, V.J. Ama Moor, B. Moukette Moukette, F. Tankeo Nsufo, B.L. Njinkio Nono, E. Sobngwi, â€œRelationship between hyperglycemia, antioxidant capacity and some enzymatic and non-enzymatic antioxidants in African patients with type 2 diabetesâ€ BMC Res. Notes, vol. 10, pp. 141, 2017.
How to Cite
- Papers must be submitted on the understanding that they have not been published elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal published by any other publisher.
- It is also the authors responsibility to ensure that the articles emanating from a particular source are submitted with the necessary approval.
- The authors warrant that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required.
- The authors ensure that all the references carefully and they are accurate in the text as well as in the list of references (and vice versa).
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.